Gel composition and method for producing the same, and three-dimensional tissue and method for producing the same

By introducing metal element ions and fragmenting extracellular matrix components into collagen gels, a transparent and highly elastic modulus gel is formed, which solves the cytotoxicity and opacity problems in the prior art and is suitable for efficient cell culture scaffolding materials .

CN115516077BActive Publication Date: 2024-12-06TOPPAN HOLDINGS INC +1
View PDF 10 Cites 0 Cited by

Patent Information

Application Number
CN202180030586.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2020-10-14
Filing Date
2021-06-16
Publication Date
2024-12-06
Estimated Expiration
2041-06-16

AI Technical Summary

Technical Problem

In the existing collagen gel preparation methods, there are problems such as cytotoxicity, difficulty in controlling elastic modulus and opaque gels, making it difficult to obtain transparent gels with high elastic modulus.

Method used

Using metal element ions containing extracellular matrix components and fragmented extracellular matrix components, a transparent and highly elastic modulus is formed by contacting the solution of metal element ions with an extracellular matrix component or a solution of fragmented extracellular matrix component. gel. It is preferred to use metal elements such as copper, zinc, palladium, platinum and gold in transition metals and base metal elements, and combine collagen as an extracellular matrix component to cross-linking treatment to improve the transparency and elasticity of the gel.

Benefits of technology

The transparent and highly elastic modulus gel composition was successfully obtained, which solved the problem of cytotoxicity and opacity, provided the convenience of observing the internal structure, and was suitable for cell culture scaffold materials.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0003904483890000011
    Figure HDA0003904483890000011
  • Figure HDA0003904483890000021
    Figure HDA0003904483890000021
  • Figure HDA0003904483890000031
    Figure HDA0003904483890000031
Patent Text Reader

Abstract

The present invention relates to a gel composition comprising at least one selected from an extracellular matrix component and a fragmented extracellular matrix component and ions of a metal element.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a gel composition and a method for producing the same. The present invention also relates to a three-dimensional tissue using the gel composition of the present invention and a method for producing the same. Background Art

[0002] Gels of extracellular matrix components such as collagen are usually used as scaffold materials during cell culture. Collagen gel is usually prepared by neutralizing and heating the collagen at about 37°C after dissolving the collagen under acidic conditions to gel the collagen. In addition, it is also known that collagen is cross-linked using cross-linking agents such as formaldehyde and glutaraldehyde to gel the collagen.

[0003] On the other hand, for example, Patent Document 1 discloses a composition containing an extracellular matrix, which comprises a fragmented extracellular matrix component obtained by fragmenting an extracellular matrix component and an aqueous medium. The composition containing an extracellular matrix disclosed in Patent Document 1 exhibits a thermoreversible sol-gel transition, and thus can be gelled and solated by temperature control.

[0004] Prior art literature

[0005] Patent Literature

[0006] Patent Document 1: International Publication No. 2019 / 208831 Summary of the invention

[0007] Technical problem to be solved by the invention

[0008] In the existing techniques for making collagen gel, there are technical problems such as the problem of cytotoxicity caused by acidic conditions or cross-linking agents, difficulty in controlling the elastic modulus, and difficulty in obtaining a gel with a high elastic modulus. On the other hand, in the method using fragmented extracellular matrix components disclosed in Patent Document 1, there is no problem of cytotoxicity, and the elastic modulus can be controlled to a certain extent, and a gel with a high elastic modulus can be obtained. However, in the method disclosed in Patent Document 1, the obtained gel is opaque and it is difficult to observe the inside.

[0009] An object of the present invention is to provide a transparent gel composition having a high elastic modulus and comprising an extracellular matrix component and / or a fragmented extracellular matrix component.

[0010] Means for solving technical problems

[0011] The present invention relates to a gel composition comprising: at least one selected from an extracellular matrix component and a fragmented extracellular matrix component; and ions of a metal element.

[0012] The gel composition of the present invention comprises an extracellular matrix component and / or a fragmented extracellular matrix component, and further comprises ions of a metal element, and thus is transparent and has a high elastic modulus. The gel composition of the present invention is based on the following insight: a transparent (hard) gel having a high elastic modulus is obtained by contacting (e.g., dropping) a solution comprising ions of a metal element with a solution comprising an extracellular matrix component and / or a fragmented extracellular matrix component.

[0013] In the gel composition, the metal element is preferably at least one metal element selected from transition metal elements and base metal elements, more preferably at least one metal element selected from transition metals of Group 10, transition metals of Group 11, and metals of Group 12 of the periodic table, and further preferably at least one selected from copper, zinc, palladium, platinum, and gold. Thus, the above effect is more significantly exerted.

[0014] In the gel composition, the extracellular matrix component preferably includes collagen, whereby the above-mentioned effect is more significantly exerted.

[0015] In the gel composition, the fragmented extracellular matrix component preferably includes fragmented collagen, whereby the above-mentioned effect is more significantly exerted.

[0016] The gel composition may be a composition in which at least one selected from the extracellular matrix component and the fragmented extracellular matrix component is cross-linked.

[0017] The present invention also relates to a method for producing a gel composition, comprising the step of bringing a solution containing at least one selected from an extracellular matrix component and a fragmented extracellular matrix component into contact with a solution containing ions of a metal element.

[0018] According to the method for producing a gel composition of the present invention, a transparent (hard) gel composition having a high elastic modulus can be obtained.

[0019] In the method for producing the gel composition, the metal element is preferably at least one metal element selected from transition metal elements and base metal elements, more preferably at least one metal element selected from transition metals of Group 10, transition metals of Group 11, and metals of Group 12 of the periodic table, and further preferably at least one selected from copper, zinc, palladium, platinum, and gold. Thus, the above effect is more significantly exerted.

[0020] In the method for producing the gel composition, the extracellular matrix component preferably includes collagen. This allows the above-mentioned effect to be more significantly exerted.

[0021] In the method for producing the gel composition, the fragmented extracellular matrix component preferably includes fragmented collagen. This allows the above-mentioned effect to be more significantly exerted.

[0022] In the method for producing the gel composition, the contacting step may be performed at a temperature of -3°C to 10°C. This avoids excessive reaction and allows the gel composition to be obtained efficiently.

[0023] The present invention also relates to a method for producing a three-dimensional tissue, which comprises the following steps: a step of obtaining a cell-containing gel composition by contacting at least one selected from extracellular matrix components and fragmented extracellular matrix components, cells, and ions of metal elements in an aqueous medium; and a step of culturing the above-mentioned cell-containing gel composition.

[0024] According to the method for producing the three-dimensional tissue, a three-dimensional tissue with a transparent appearance can be obtained. Therefore, cells inside the three-dimensional tissue can be easily observed. In addition, according to the method for producing the three-dimensional tissue, a three-dimensional tissue with a high elastic modulus can be obtained.

[0025] In the above-mentioned method for producing a three-dimensional tissue body, the step of obtaining the cell-containing gel composition may include a step of contacting a solution containing ions of the above-mentioned metal element and a second aqueous medium with a suspension containing at least one selected from the above-mentioned extracellular matrix components and the above-mentioned fragmented extracellular matrix components, the above-mentioned cells and the first aqueous medium.

[0026] In the method for producing the three-dimensional tissue body, the culturing step may be performed under conditions in which at least a part of the cells remain alive.

[0027] The method for producing a three-dimensional tissue body may further include a step of incubating the gel composition at 20° C. to 30° C. after the step of obtaining the cell-containing gel composition and before the step of culturing.

[0028] In the above-mentioned method for producing a three-dimensional structure, the above-mentioned metal element may be at least one metal element selected from transition metal elements and base metal elements.

[0029] The present invention also relates to a three-dimensional tissue body, which contains at least one selected from the group consisting of an extracellular matrix component and a fragmented extracellular matrix component, cells, and ions of a metal element, and is transparent at 37°C.

[0030] The total light transmittance of the three-dimensional tissue at 37° C. may be 80% or more.

[0031] In the three-dimensional structure, the metal element may be at least one metal element selected from transition metal elements and base metal elements.

[0032] Effects of the Invention

[0033] According to the present invention, a gel composition which is transparent and has a high elastic modulus and contains an extracellular matrix component and / or a fragmented extracellular matrix component can be provided. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 The following are photographs showing the results of Test Example 1.

[0035] Figure 2 The following are photographs showing the results of Test Example 2.

[0036] Figure 3 The following are photographs showing the results of Test Example 3.

[0037] Figure 4 The following are photographs showing the results of Test Example 4.

[0038] Figure 5 To show the appearance of the three-dimensional tissue produced in Experimental Example 6 ( Figure 5 (A)) and internal ( Figure 5 (B))Photo.

[0039] Figure 6 It is a graph showing the elastic modulus of the gel composition prepared from the solution of each metal ion.

[0040] Figure 7 (A) shows the concentrations of fragmented collagen solution and Pt 2+ (B) is a graph showing the transmittance of the gel composition prepared from the solutions at a wavelength of 500 nm. (C) is a graph showing the transmittance of the gel composition prepared from the solutions at various concentrations and Pt 2+ Image of gel made from solution.

[0041] Figure 8 The following are photographs showing the results of Test Example 9. DETAILED DESCRIPTION

[0042] Hereinafter, the mode for implementing the present invention will be described in detail. However, the present invention is not limited to the following embodiment.

[0043] [Gel composition]

[0044] The gel composition of the present embodiment contains at least one selected from the group consisting of an extracellular matrix component and a fragmented extracellular matrix component, and ions of a metal element.

[0045] The extracellular matrix component is the aggregate of extracellular matrix molecules formed by a plurality of extracellular matrix molecules. Extracellular matrix molecules can be substances present in the extracellular in multicellular organisms. As extracellular matrix molecules, as long as the formation of the propagation of cells and cell aggregates is not adversely affected, any substance can be used. As extracellular matrix molecules, collagen, laminin, fibronectin, vitronectin, elastin, tenascin, nidogen, fibrillin, and proteoglycans etc. can be enumerated, but are not limited to these. As extracellular matrix components, these extracellular matrix molecules can be used one individually, and more than two can also be used in combination.

[0046] The extracellular matrix component, for example, may include collagen or may be composed of collagen. When the extracellular matrix component includes collagen, the effect of the present invention that the gel composition is transparent and the elastic modulus of the gel composition is high (hard) can be more significantly exerted. In addition, when the extracellular matrix component includes collagen, when the gel composition of the present embodiment is used as a scaffold material during cell culture, collagen functions as a scaffold for cell adhesion, further promoting the formation of a three-dimensional cell structure.

[0047] The extracellular matrix molecule can also be a modified body and variant of the above-mentioned extracellular matrix molecule, or a polypeptide such as a chemically synthesized peptide. The extracellular matrix molecule can be a molecule having a repetitive sequence shown in Gly-XY, which is characteristic of collagen. Here, Gly represents a glycine residue, and X and Y each independently represent an arbitrary amino acid residue. A plurality of Gly-XYs can be the same or different. By having a repetitive sequence shown in Gly-XY, the function of a scaffold material during, for example, cell culture becomes more excellent due to the reduction of the constraint on the molecular chain configuration. In the repetitive extracellular matrix molecule having a sequence shown in Gly-XY, the proportion of the sequence shown in Gly-XY in the total amino acid sequence can be more than 80%, preferably more than 95%. In addition, the extracellular matrix molecule can also be a polypeptide having an RGD sequence. The RGD sequence refers to the sequence shown in Arg-Gly-Asp (arginine residue-glycine residue-aspartic acid residue). By having an RGD sequence, it becomes more preferred as a scaffold material during, for example, cell culture due to further promoting cell adhesion. Examples of the extracellular matrix molecule comprising a sequence represented by Gly-XY and an RGD sequence include collagen, fibronectin, vitronectin, laminin, and cadherin.

[0048] Examples of collagen include fibrous collagen and non-fibrous collagen. Fibrous collagen refers to collagen that is the main component of collagen fibers, and specifically includes type I collagen, type II collagen, type III collagen, etc. Examples of non-fibrous collagen include type IV collagen.

[0049] Examples of the proteoglycan include chondroitin sulfate proteoglycan, heparan sulfate proteoglycan, keratan sulfate proteoglycan, and dermatan sulfate proteoglycan, but are not limited thereto.

[0050] The extracellular matrix component can include at least one selected from collagen, laminin and fibronectin for the reason that the effect of the present invention becomes more significant, preferably collagen. Collagen is preferably fibrous collagen, more preferably type I collagen. Fibrous collagen can use commercially available collagen, and as its specific example, type I collagen derived from pig skin manufactured by Ham Co., Ltd. of Japan can be cited.

[0051] The extracellular matrix component can also be an extracellular matrix component of animal origin. As the animal species that becomes the extracellular matrix component source, for example, humans, pigs, cattle, etc. can be enumerated, but are not limited to these. The extracellular matrix component can use a component of an animal origin, and can also use a variety of animal-derived components.

[0052] Fragmented extracellular matrix components can be obtained by fragmenting the above-mentioned extracellular matrix components." fragmentation " refers to making the aggregate of extracellular matrix molecules into a smaller size. Fragmentation can be carried out under the condition that the key in the extracellular matrix molecule is cut, or it can be carried out under the condition that the key in the extracellular matrix molecule is not cut. The fragmented extracellular matrix components can include the composition after the above-mentioned extracellular matrix components are defibrated by the application of physical force, i.e. the extracellular matrix components (fibrillated extracellular matrix components) defibrated. Fibrillation is a mode of fragmentation, for example, carried out under the condition that the key in the extracellular matrix molecule is not cut.

[0053] As the method by extracellular matrix component fragmentation, there is no particular restriction.As the method by which the extracellular matrix component is fibrillated, for example, the extracellular matrix component can be fibrillated by the application of the physical force such as ultrasonic homogenizer, stirring homogenizer, and high-pressure homogenizer.When using stirring homogenizer, the extracellular matrix component can be directly homogenized, and it is also possible to homogenize in aqueous media such as physiological saline.In addition, by adjusting the time, number of times etc. of homogenization, it is also possible to obtain the fibrillated extracellular matrix component of millimeter size, nanometer size. The fibrillated extracellular matrix component can also be obtained by fibrillating by repeated freezing and thawing.

[0054] The fragmented extracellular matrix component can include the fibrillated extracellular matrix component in at least a portion. In addition, the fragmented extracellular matrix component can also be composed of only the fibrillated extracellular matrix component. That is, the fragmented extracellular matrix component can be the fibrillated extracellular matrix component. The fibrillated extracellular matrix component preferably includes the fibrillated collagen component (fibrillated collagen component). The fibrillated collagen component preferably maintains the triple helical structure of the collagen source. The fibrillated collagen component can also be a component that partially maintains the triple helical structure of the collagen source.

[0055] As the shape of the fragmented extracellular matrix component, for example, a fibrous shape can be cited. A fibrous shape refers to a shape consisting of a filamentous collagen component or a filamentous extracellular matrix component that is cross-linked between molecules. At least a portion of the fragmented extracellular matrix component can also be fibrous. The fibrous extracellular matrix component includes a thin filament (thin fiber) formed by the collection of multiple filamentous extracellular matrix molecules, a filament formed by further collection of thin fibers, and a material after the fibrillation of these filaments. In the fibrous extracellular matrix component, the RGD sequence is not destroyed and is retained.

[0056] The average length of the fragmented extracellular matrix component can be more than 100nm and less than 400μm, or more than 100nm and less than 200μm. In one embodiment, the average length of the fragmented extracellular matrix component can be more than 5μm and less than 400μm, or more than 10μm and less than 400μm, or more than 22μm and less than 400μm, or more than 100μm and less than 400μm. In other embodiments, the average length of the fragmented extracellular matrix component can be less than 100μm, or less than 50μm, or less than 30μm, or less than 15μm, or less than 10μm, or less than 1μm, or more than 100nm from the viewpoint that redispersibility becomes more excellent. The average length of most of the fragmented extracellular matrix components in the preferred fragmented extracellular matrix component as a whole is within the above numerical range. Specifically, the average length of 95% of the fragmented extracellular matrix components in the preferred fragmented extracellular matrix component as a whole is within the above numerical range. The fragmented extracellular matrix component is preferably a fragmented collagen component whose average length is within the above range, and more preferably a defibrillated collagen component whose average length is within the above range.

[0057] The average diameter of the fragmented extracellular matrix component can be 10 nm or more and 30 μm or less, 30 nm or more and 30 μm or less, 50 nm or more and 30 μm or less, 100 nm or more and 30 μm or less, 1 μm or more and 30 μm or less, 2 μm or more and 30 μm or less, 3 μm or more and 30 μm or less, 4 μm or more and 30 μm or less, or 5 μm or more and 30 μm or less. The fragmented extracellular matrix component is preferably a fragmented collagen component having an average diameter within the above range, and more preferably a defibrillated collagen component having an average diameter within the above range.

[0058] The average length and average diameter of the fragmented extracellular matrix components can be obtained by measuring each fragmented extracellular matrix component using an optical microscope and performing image analysis. In this specification, "average length" refers to the length average value of the length direction of the measured sample, and "average diameter" refers to the length average value in a direction orthogonal to the length direction of the measured sample.

[0059] The fragmented extracellular matrix component generally becomes an opaque gel when it is gelled, but the gel composition of the present invention becomes a transparent gel even when it contains the fragmented extracellular matrix component.

[0060] The gel composition of this embodiment may be cross-linked between or within molecules of at least a portion of the extracellular matrix components and / or fragmented extracellular matrix components (hereinafter also collectively referred to as "extracellular matrix components, etc."). The extracellular matrix components, etc. may be cross-linked within the molecules constituting the extracellular matrix components, etc., or may be cross-linked between the molecules constituting the extracellular matrix components, etc.

[0061] The cross-linking of the extracellular matrix components etc. may be at least partially due to the formation of hydrogen bonds between the carboxyl groups etc. of the extracellular matrix molecules and the metal element ions. The cross-linking of the extracellular matrix components etc. may also include physical cross-linking by applying heat, ultraviolet rays, radiation etc., chemical cross-linking by cross-linking agents, enzyme reactions etc.

[0062] The type of the metal element ions contained in the gel composition of the present embodiment is not particularly limited, and any metal element ions can be used.

[0063] From the viewpoint of being able to more significantly exert the effect of the present invention that the gel composition is transparent and the elastic modulus of the gel composition is high (hard), the metal element is preferably at least one metal element selected from transition metal elements and base metal elements. Specific examples of at least one metal element selected from transition metal elements and base metal elements include titanium (Ti), copper (Cu), zinc (Zn), palladium (Pd), platinum (Pt), gold (Au), etc. Specific examples of ions of at least one metal element selected from transition metal elements and base metal elements include Ti. + 、Ti 2+ 、Ti 3+ 、Ti 4+ , Cu + , Cu 2+ 、Zn + 、Zn 2+ , Pd 2+ , Pd 4+ , Pt 2+ , Pt 4+ 、Au + 、Au 2+ 、Au 4+ wait.

[0064] From the viewpoint of being able to more significantly exert the effects of the present invention, the metal element is more preferably at least one metal element selected from the transition metals of the 10th group, the transition metals of the 11th group, and the metals of the 12th group of the periodic table. Specific examples of at least one metal element selected from the transition metals of the 10th group, the transition metals of the 11th group, and the metals of the 12th group of the periodic table include copper (Cu), zinc (Zn), palladium (Pd), platinum (Pt), and gold (Au). Specific examples of ions of at least one metal element selected from the transition metals of the 10th group, the transition metals of the 11th group, and the metals of the 12th group of the periodic table include Cu. 2+ 、Zn 2+ , Pd 2+ , Pd 4+ , Pt 2+ , Pt 4+ 、Au + 、Au 2+ 、Au 4+ wait.

[0065] The ions of the metal element used in the gel composition of this embodiment are preferably ions of metal elements selected from titanium (Ti), copper (Cu), zinc (Zn), platinum (Pt) and gold (Au) from the viewpoint of having no cytotoxicity or low cytotoxicity and being safe for the living body. When the gel composition is safe for the living body, for example, the gel composition can be preferably used as a scaffold material for cell culture when forming an artificial tissue.

[0066] Since the gel composition of the present embodiment is transparent, the inside is easy to observe. Therefore, for example, it can be preferably used as a scaffold material for cell culture when forming artificial tissue. The total light transmittance of the gel composition of the present embodiment is, for example, 80% or more, 85% or more, 90% or more, or 95% or more. The total light transmittance is a test piece formed by preparing a gel composition with a thickness of 10 mm, and is defined as the ratio of the transmitted light beam (including the diffused component) of the test piece to the parallel incident light beam.

[0067] Since the gel composition of the present embodiment has a high elastic modulus, it can be preferably used as a scaffold material during cell culture when artificially forming cancer tissue, for example. Thus, a (hard) artificial cancer tissue with a high elastic modulus can be formed. The elastic modulus of the gel composition of the present embodiment can be 1.5 kPa or more, 2.0 kPa or more, 5.0 kPa or more, 10 kPa or more, or 50 kPa or more. There is no particular limit to the upper limit of the elastic modulus, which is usually 250 kPa or less, preferably 200 kPa or less, and more preferably 150 kPa or less. The elastic modulus is a value measured by the method described in the examples described below.

[0068] The content of at least one selected from the extracellular matrix component and the fragmented extracellular matrix component in the gel composition of the present embodiment may be, for example, 0.01% by weight or more, 0.05% by weight or more, 0.1% by weight or more, 0.15% by weight or more, 0.2% by weight or more, 0.5% by weight or more, 1.0% by weight or more, 2.0% by weight or more, or 3.0% by weight or more, based on the total amount of the gel composition. The upper limit of the content of at least one selected from the extracellular matrix component and the fragmented extracellular matrix component is not particularly limited as long as it can be prepared, and may be, for example, 10.0% by weight or less, or 5.0% by weight or less, based on the total amount of the gel composition.

[0069] The content of the metal element ions in the gel composition of this embodiment can be, for example, 5 mg or more, 10 mg or more, 20 mg or more, 30 mg or more, or 40 mg or more, relative to 1 g of the total content of at least one selected from the extracellular matrix component and the fragmented extracellular matrix component. The content of the metal element ions is not particularly limited, and can be, for example, 100 mg or less, 80 mg or less, or 60 mg or less, relative to 1 g of the total content of at least one selected from the extracellular matrix component and the fragmented extracellular matrix component.

[0070] The gel composition of this embodiment may further contain other components other than at least one selected from the group consisting of extracellular matrix components and fragmented extracellular matrix components and ions of metal elements, depending on the application of the gel composition. For example, when the gel composition is used as a scaffold material for cell culture, other components may include nutrients for cells to be cultured, pH regulators, etc.

[0071] [Method for producing gel composition]

[0072] The gel composition of the present embodiment can be obtained, for example, by a production method comprising a step of contacting a solution containing at least one selected from an extracellular matrix component and a fragmented extracellular matrix component with a solution containing ions of a metal element (contact step).

[0073] The solution containing at least one selected from the group consisting of the extracellular matrix components and the fragmented extracellular matrix components can be obtained by dissolving or dispersing the extracellular matrix components and / or the fragmented extracellular matrix components in a solvent. The solvent is not particularly limited as long as it is a solvent capable of dissolving or dispersing the extracellular matrix components and / or the fragmented extracellular matrix components, and specifically includes water, physiological saline such as phosphate buffered saline (PBS), and liquid culture media such as Dulbecco's Modified Eagle medium (DMEM).

[0074] The solution containing the ions of the metal element is not particularly limited as long as it contains the ions of the above-mentioned metal element. The ion source of the metal element ion is also not particularly limited, and can be, for example, an inorganic salt, an organic salt, etc. The solution containing the ions of the metal element can be obtained by dissolving the ion source of the metal element ion in a solvent, for example. The solvent is not particularly limited as long as it is a solvent capable of dissolving the ion source of the metal element ion, and can be, for example, an organic solvent such as water, ethanol, and dimethyl sulfoxide (DMSO).

[0075] As long as the contact process is a method for contacting a solution containing at least one selected from an extracellular matrix component and a fragmented extracellular matrix component with a solution containing ions of a metal element, any method can be used. Specifically, for example, a method for contacting a solution containing at least one selected from an extracellular matrix component and a fragmented extracellular matrix component and a solution containing ions of a metal element can be cited. When mixing, it is preferably mixed in a manner that the two solutions become uniform. In addition, from the viewpoint that the formation efficiency of the gel becomes higher, it is preferably contacted by stirring a solution containing at least one selected from an extracellular matrix component and a fragmented extracellular matrix component, and dripping a solution containing ions of a metal element therein. The dripping speed can, for example, exemplify 1 drop / second.

[0076] The temperature during the contacting step is not particularly limited, but is preferably 10° C. or lower, more preferably 5° C. or lower, from the viewpoint of avoiding excessive reaction. The lower limit of the temperature is not particularly limited, but is usually -3° C. or higher, preferably 0° C. or higher.

[0077] The contact time of the two solutions during the contact process is appropriately set according to the type of extracellular matrix components and / or fragmented extracellular matrix components used and the type of ions of the metal element, in accordance with the manner in which gel formation occurs. The contact time is usually more than 0 seconds (gelation occurs immediately after contact) and less than 30 minutes. For example, when the fragmented collagen solution is mixed with Pd 2+ When the solution contacts, gelation occurs instantly upon contact, so a contact time of 0 seconds or more and 10 seconds or less is sufficient. 4+ When the solutions are brought into contact, a gel can be formed by setting the contact time to 10 minutes to 20 minutes.

[0078] [How to use the gel composition]

[0079] The gel composition of the present embodiment is transparent and has a high elastic modulus (hard), and therefore is preferably used as a scaffold material for forming a cell structure (three-dimensional tissue), for example.

[0080] [Three-dimensional tissue]

[0081] A three-dimensional tissue is a collection of cells in which cells are three-dimensionally arranged via an extracellular matrix component, and is an artificial collection made by cell culture. The shape of the three-dimensional tissue is not particularly limited, and examples thereof include a sheet, a sphere, an ellipsoid, a cuboid, and the like.

[0082] The three-dimensional tissue of the present embodiment contains at least one selected from the group consisting of extracellular matrix components and fragmented extracellular matrix components, cells, and ions of metal elements. At least a portion of the cells may also contact the extracellular matrix components and / or fragmented extracellular matrix components. As a form of contact, adhesion may be used.

[0083] The three-dimensional tissue of this embodiment can be transparent at 37° C., for example. Specifically, the total light transmittance at 37° C. can be 80% or more, 85% or more, 90% or more, or 95% or more. The total light transmittance is defined based on the total light transmittance of the gel composition.

[0084] The cells included in the three-dimensional tissue of the present embodiment are not particularly limited, and may be, for example, cells of animal origin such as humans, monkeys, dogs, cats, rabbits, pigs, cattle, mice, rats, etc. The source of the cells is also not particularly limited, and may be somatic cells of bone, muscle, viscera, nerves, brain, bone, skin, blood, etc., or reproductive cells. Furthermore, the cells may also be induced pluripotent stem cells (iPS cells), embryonic stem cells (ES cells), and may also be cultured cells such as primary culture cells, subculture cells, and cell line cells. Specifically, as cells, for example, neural cells, dendritic cells, immune cells, vascular endothelial cells (for example, human umbilical vein-derived vascular endothelial cells (HUVEC)), lymphatic endothelial cells, fibroblasts, colorectal cancer cells (for example, human colorectal cancer cells (HT29)), cancer cells such as liver cancer cells, epithelial cells (for example, human gingival epithelial cells), keratinocytes, cardiomyocytes (for example, human iPS cell-derived cardiomyocytes (iPS-CM)), hepatocytes, pancreatic islet cells, tissue stem cells, smooth muscle cells (for example, aorta smooth muscle cells (Aorta-SMC), etc., but are not limited to these. One type of cell may be used alone, or a plurality of cells may be used in combination.

[0085] Specific aspects of the extracellular matrix components, fragmented extracellular matrix components, and ions of metal elements contained in the three-dimensional tissue of this embodiment are the same as those described in the gel composition of the present invention.

[0086] The thickness of the three-dimensional tissue body of the present embodiment is preferably 10 μm or more, more preferably 100 μm or more, and further preferably 1000 μm or more. This three-dimensional tissue body is a structure closer to biological tissue, and is preferably used as a substitute for experimental animals and a transplant material. The upper limit of the thickness of the three-dimensional tissue body of the present embodiment is not particularly limited, for example, it can be less than 10 mm, can also be less than 3 mm, can also be less than 2 mm, can also be less than 1.5 mm, and can also be less than 1 mm. Here, the thickness of the three-dimensional tissue body refers to the distance between the two ends in the direction orthogonal to the main surface when the three-dimensional tissue body is in the form of a sheet or a rectangular parallelepiped. When the main surface has concavoconvexity, the thickness refers to the distance at the thinnest part of the above-mentioned main surface. In addition, when the three-dimensional tissue body is spherical, it refers to its diameter. Furthermore, when the three-dimensional tissue body is ellipsoidal, it refers to its short diameter. When the three-dimensional tissue body is roughly spherical or roughly ellipsoidal, and the surface has concavoconvexity, the thickness refers to the shortest distance between the two points where the straight line passing through the center of gravity of the three-dimensional tissue body intersects with the above-mentioned surface.

[0087] [Method for producing three-dimensional tissue]

[0088] The three-dimensional tissue of the present embodiment can be obtained, for example, by a manufacturing method having the following steps: a step of obtaining a cell-containing gel composition by contacting at least one selected from an extracellular matrix component and a fragmented extracellular matrix component (hereinafter also referred to as "extracellular matrix component, etc."), cells, and ions of metal elements in an aqueous medium (contact step); and a step of culturing the cell-containing gel composition obtained in the contact step (culturing step). The manufacturing method of the present embodiment can also further include a step of incubating the cell-containing gel composition at 20°C to 30°C (incubation step) after the contact step and before the culturing step.

[0089] The contacting step is a step of obtaining a cell-containing gel composition by contacting the extracellular matrix components, cells, and ions of metal elements in an aqueous medium. An aqueous medium refers to a liquid having water as an essential component. Examples of aqueous media include physiological saline such as phosphate buffered saline (PBS), and liquid culture media such as Dulbecco's Modified Eagle medium (DMEM). The liquid culture medium may also be a mixed culture medium in which two culture media are mixed. From the viewpoint of reducing the load on the cells, the aqueous medium is preferably a liquid culture medium.

[0090] The liquid culture medium is not particularly limited, and a preferred culture medium can be selected according to the type of cells to be cultured. As the above-mentioned culture medium, for example, Eagle's MEM culture medium, DMEM, Modified Eagle culture medium (MEM), Minimum Essential culture medium, RPMI culture medium, and GlutaMax culture medium can be cited. The culture medium can be a culture medium supplemented with serum, or a serum-free culture medium. Furthermore, the liquid culture medium can also be a mixed culture medium in which two or more culture media are mixed.

[0091] Specific aspects of the extracellular matrix component and the like and the ions of the metal element used in the contacting step are the same as those described in the gel composition of the present invention.

[0092] The contacting step may also include, for example, a step of contacting a solution containing ions of metal elements and a second aqueous medium with a suspension containing extracellular matrix components, cells, and a first aqueous medium. In this case, the first aqueous medium and the second aqueous medium may be the same or different. The suspension may be obtained, for example, by mixing a solution in which extracellular matrix components, etc. are dissolved in a first aqueous medium with cells.

[0093] The concentration of the extracellular matrix components in the contact process can be appropriately determined according to the shape, thickness, size of the culture vessel, etc. of the target three-dimensional tissue. For example, the concentration of the extracellular matrix components in the aqueous medium in the contact process can be 0.1 to 30% by mass, or 0.1 to 10% by mass, based on the total amount of the aqueous medium (e.g., the total amount of the first aqueous medium and the second aqueous medium). In addition, for example, the amount of the extracellular matrix components relative to 1×10 6 The amount of cells may be 0.01 to 1000 μg, 0.1 to 100 μg, or 0.1 to 5 μg.

[0094] The culturing step is a step of culturing the cell-containing gel composition obtained in the contacting step. The culturing step is preferably carried out under conditions in which at least a portion of the cells contained in the cell-containing gel composition remain alive. The conditions for maintaining the alive state can be appropriately set according to the type of cells. Specifically, the following culturing conditions can be cited.

[0095] The culture conditions in the culture step can be set to preferred culture conditions according to the type of cells. For example, the culture temperature can be 20°C to 40°C, or 30°C to 37°C. The pH of the culture medium can be 6 to 8, or 7.2 to 7.4. The culture time can be 1 day to 14 days, or 7 days to 14 days, or 14 days to 30 days, or 30 days to 60 days, or 60 days to 90 days.

[0096] The cell density in the cell-containing gel composition can be appropriately determined according to the shape and thickness of the target three-dimensional tissue. For example, the cell density in the cell-containing gel composition can be 1 to 10 8 cells / ml, or 10 3 ~10 7 cells / ml.

[0097] The incubation step is a step of incubating the cell-containing gel composition at 20°C to 30°C after the contact step and before the culture step. The incubation step is a step implemented to more reliably form a gel using extracellular matrix components and ions of metal elements. The incubation step can be implemented as needed. The incubation time can be appropriately set according to the type of extracellular matrix components and ions of metal elements used, and for example, 30 minutes to 24 hours can be exemplified.

[0098] Example

[0099] The present invention will be described in more detail below based on test examples, but the present invention is not limited to the following test examples.

[0100] [Test Example 1: Production of gel composition]

[0101] (Preparation of collagen solution)

[0102] 1 g of mixed type I and type III collagen from pig skin produced by Ham Co., Ltd. of Japan was added to 500 mL of ultrapure water, and incubated at 4°C for 12 hours to prepare a 0.2 wt% collagen solution. After that, 0.45 M NaCl and 5 mM Tris-HCl were added to the collagen solution, and after incubation at 4°C for 12 hours, 1.2 M NaCl was added, and then incubated at 4°C for another 12 hours. After incubation, centrifugation was performed at 10,000 rpm for 15 minutes, and the supernatant was recovered to obtain a purified type I collagen solution. The obtained type I collagen solution was dialyzed with ultrapure water for 7 days (molecular weight cutoff (MWCO): 15 kDa), and then freeze-dried for 3 days to obtain purified type I collagen.

[0103] The obtained purified type I collagen was added to PBS (pH 7), and incubated at 4°C for 12 hours to prepare a 0.2 wt % type I collagen solution.

[0104] (Au 3+ Solution Preparation)

[0105] A 12.5 mM Au solution was prepared by adding a sodium hydroxide (NaOH) solution or water to a tetrachloroauric acid (III) (HAuCl4) aqueous solution. 3+ solution (pH 6.8) or 12.5 mM Au 3+Solution (pH 2.2). As a control, hydrochloric acid (HCl aqueous solution, pH 2.2) was prepared.

[0106] (Preparation of gel composition)

[0107] <Example 1>

[0108] 6 mL of 0.2 wt% type I collagen solution was placed in a container equipped with a stirring bar and stirred while being cooled in an ice bath. Next, 240 μL of Au was added dropwise while stirring the collagen solution in the ice bath. 3+ Solution (pH 6.8) (Au 3+ :3 μmol).

[0109] <Example 2>

[0110] In addition to replacing Au 3+ 240 μL of Au was added to the solution (pH 6.8) 3+ Solution (pH 2.2) (Au 3+ The same operation as in Example 1 was carried out except that the amount of NH4Cl2O3 was 3 μmol.

[0111] <Comparative Example 1>

[0112] In addition to replacing Au 3+ The same operation as in Example 1 was carried out except that 240 μL of hydrochloric acid (pH 2.2) was added dropwise to the solution (pH 6.8).

[0113] (Determination of elastic modulus)

[0114] The elastic modulus of the gel was measured using a small tabletop tester EZ-test (manufactured by Shimadzu Corporation). Specifically, the gel was tested using a rod-shaped fixture (front end area: 11 mm 2 ) was compressed at a temperature of 25°C and a compression speed of 1 mm / min to obtain a stress-strain curve. The Young's modulus (kPa) was calculated from the slope of the elastic deformation region at the initial stress increase in the obtained stress-strain curve as the elastic modulus.

[0115] (result)

[0116] Figure 1 To indicate the addition of Au 3+ The photographs of the appearance of each composition after 10 minutes have passed since the addition of the solution or hydrochloric acid. Figure 1 In the figure, container 1 represents the one where Au is added. 3+ The composition of the solution (pH 6.8), container 2 represents the addition of Au 3+The container 3 represents a composition of a solution (pH 2.2), and the container 3 represents a composition to which hydrochloric acid (pH 2.2) is added dropwise.

[0117] like Figure 1 As shown in the figure, Au was added to type I collagen. 3+ The composition of container 1 containing the solution (pH 6.8) became a transparent gel (elastic modulus 2.2 kPa). 3+ The composition in container 2 containing the solution (pH 2.2) turned into a transparent gel (elastic modulus 2.2 kPa). On the other hand, the composition in container 3 containing type I collagen with hydrochloric acid (pH 2.2) added dropwise did not gel. These results show that the gelation of collagen is not based on pH but on metal ions (Au 3+ )’s existence.

[0118] [Test Example 2: Production of gel composition]

[0119] (Preparation of collagen solution)

[0120] A 0.2 wt% type I collagen solution was prepared by the same operation as in Test Example 1. Separately, 1 g of pig skin-derived type I and type III mixed collagen manufactured by Ham Co., Ltd. was added to 500 mL of ultrapure water and incubated at 4°C for 12 hours to prepare a 0.2 wt% type I and type III mixed collagen solution.

[0121] (Au 3+ Solution Preparation)

[0122] Using the same procedure as in Experimental Example 1, 12.5 mM Au 3+ Solution (pH 6.8).

[0123] (Preparation of gel composition)

[0124] <Example 3>

[0125] 6 mL of 0.2 wt% type I collagen solution was placed in a container equipped with a stirring bar and stirred while being cooled in an ice bath. Next, 240 μL of Au was added dropwise while stirring the collagen solution in the ice bath. 3+ Solution (pH 6.8) (Au 3+ :3 μmol).

[0126] <Example 4>

[0127] 6 mL of a 0.2 wt% mixed type I and type III collagen solution was placed in a container equipped with a stirring bar and stirred while being cooled in an ice bath. Next, 240 μL of Au was added dropwise while stirring the collagen solution in an ice bath. 3+Solution (pH 6.8) (Au 3+ :3 μmol).

[0128] (result)

[0129] Figure 2 To indicate the addition of Au 3+ The photographs of the appearance of each composition after 10 minutes from the solution. Figure 2 In the figure, container 1 represents the type I collagen solution to which Au is added. 3+ The composition of the solution (pH 6.8), container 6 represents the addition of Au to the mixed collagen solution of type I and type III 3+ The composition of the solution (pH 6.8).

[0130] like Figure 2 As shown in the figure, Au was added to the type I collagen solution. 3+ The composition in container 1 of the solution (pH 6.8) turned into a transparent gel (elastic modulus 2.2 kPa). Similarly, Au was added dropwise to the mixed type I and type III collagen solution. 3+ The solution (pH 6.8) of the composition in container 6 also turned into a transparent gel, but it was a softer gel than the gel composition in container 1.

[0131] [Test Example 3: Production of gel composition]

[0132] (Preparation of collagen solution)

[0133] By the same operation as in Test Example 1, a 0.2 wt % type I collagen solution was prepared.

[0134] (Preparation of fragmented collagen solution)

[0135] 50 mg of purified type I collagen obtained by the same operation as in Test Example 1 was suspended in 5 mL of 1×PBS (pH=7), homogenized at room temperature for 6 minutes using a stirring homogenizer, and then incubated at 4°C for 3 days to obtain a 1 wt% fragmented collagen solution. The average diameter of the fragmented collagen in the obtained fragmented collagen solution was 84.4±43.0 nm (N=25).

[0136] (Pd 2+ Solution Preparation)

[0137] Prepare 12.5 mM Pd by dissolving palladium chloride (H2PdCl4) in water. 2+ Solution (pH 1.1).

[0138] (Preparation of gel composition)

[0139] <Example 5>

[0140] 6 mL of 0.2 wt% type I collagen solution was placed in a container equipped with a stirring bar and stirred while being cooled in an ice bath. Next, 240 μL of Pd 2+ Solution (Pd 2+ :3 μmol).

[0141] <Example 6>

[0142] 6 mL of a 1 wt% fragmented collagen solution was placed in a container equipped with a stirring bar and stirred while being cooled in an ice bath. Next, 240 μL of Pd 2+ Solution (Pd 2 + :3 μmol).

[0143] (result)

[0144] Figure 3 To indicate the addition of Pd 2+ The photographs of the appearance of each composition after 10 minutes from the solution. Figure 3 Container 7 shows the type I collagen solution to which Pd 2+ The composition of the solution, container 8 represents the fragmented collagen solution to which Pd 2+ The composition of the solution.

[0145] like Figure 3 As shown in the figure, Pd was added to the type I collagen solution. 2+ The composition of the solution container 7 is obviously derived from Pd 2+ The fragmented collagen solution was added with Pd 2+ The composition of the solution container 8 can also be seen from Pd 2+ In particular, the composition of container 8 to which Pd 2+ Part of the solution gelled instantaneously, forming a harder gel.

[0146] [Test Example 4: Production of gel composition]

[0147] (Preparation of collagen solution)

[0148] By the same operation as in Test Example 1, a 0.2 wt % type I collagen solution was prepared.

[0149] (Au + Solution Preparation)

[0150] Chloro[(tetrahydrothiophen-1-yl)-1-yl]gold(III) was dissolved in dimethyl sulfoxide (DMSO) to prepare 12.5 mM Au + Solution.

[0151] (Preparation of gel composition)

[0152] <Example 7>

[0153] 6 mL of 0.2 wt% type I collagen solution was placed in a container equipped with a stirring bar and stirred while being cooled in an ice bath. Next, 240 μL of Au was added dropwise while stirring the collagen solution in the ice bath. + Solution (Au + :3 μmol).

[0154] <Comparative Example 2>

[0155] 6 mL of a 0.2 wt% type I collagen solution was placed in a container equipped with a stirring bar, and stirred while cooling in an ice bath. Next, DMSO was added dropwise thereto while stirring the collagen solution in the ice bath.

[0156] <Comparative Example 3>

[0157] 6 mL of a 0.2 wt% type I collagen solution was placed in a container with a stirring rod, cooled in an ice bath, and stirred. Next, while stirring the collagen solution in an ice bath, chloro[(tetrahydrothiophen-1-ium)-1-yl]gold(III) powder was added thereto. Furthermore, stirring was continued even after the addition, but the powder did not dissolve in the solution.

[0158] (result)

[0159] Figure 4 To indicate the Au + The photographs are of the appearance of each composition at 10 minutes after the dropwise addition or addition of a solution, DMSO or chloro[(tetrahydrothiophen-1-yl)-1-yl]gold(III) powder. Figure 4 In the embodiment, container 9 represents a composition in which DMSO is added dropwise to a type I collagen solution, and container 10 represents a composition in which Au is added dropwise to a type I collagen solution. + The composition of the solution and the container 11 represent a composition in which chloro[(tetrahydrothiophen-1-yl)-1-yl]gold(III) powder is added to the type I collagen solution.

[0160] like Figure 4 As shown in the figure, although the composition in container 9 in which the DMSO solution was dropped into the type I collagen solution was partially gelled in the dropped portion, no gelation of the entire solution was confirmed. +The composition in container 10 of the solution became a transparent gel. On the other hand, in the composition in container 11 of the type I collagen solution to which chloro[(tetrahydrothiophen-1-ium)-1-yl]gold(III) powder was added, the powder did not dissolve in the solution.

[0161] [Test Example 5: Production of gel composition]

[0162] (Preparation of collagen solution)

[0163] By the same operation as in Test Example 3, a 1 wt % fragmented collagen solution was prepared.

[0164] (Pt 4+ Solution Preparation)

[0165] Dissolve hexachloroplatinic acid (H2PtCl6) in water to prepare 12.5M Pt 4+ Solution.

[0166] (Preparation of gel composition)

[0167] <Example 8>

[0168] 6 mL of a 1 wt% fragmented collagen solution was placed in a container equipped with a stirring bar, and stirred while being cooled in an ice bath. Next, the fragmented collagen solution was allowed to stand in an ice bath, and 240 μL of Pt 4+ Solution (Pt 4+ :3 μmol).

[0169] (result)

[0170] Pt was added to the type I collagen solution. 4+ The solution composition did not gel immediately after the dropwise addition, but turned into a transparent gel (elastic modulus: 89 kPa) after being left to stand in an ice bath for 15 minutes.

[0171] [Test Example 6: Production and Evaluation of Three-Dimensional Organoids]

[0172] (Preparation of collagen solution)

[0173] By the same operation as in Test Example 1, a 0.2 wt % type I collagen solution was prepared.

[0174] (Preparation of fragmented collagen solution)

[0175] 50 mg of purified type I collagen obtained by the same operation as in Test Example 1 was suspended in 5 mL of 1×PBS (pH=7), homogenized at room temperature for 6 minutes using a stirring homogenizer, and then incubated at 4°C for 3 days to obtain a 1.0 wt% fragmented collagen solution. Furthermore, the fragmented collagen solution was diluted with RPMI-1640 medium to obtain a 0.5 wt% fragmented collagen solution.

[0176] (Pt 2+ Solution Preparation)

[0177] Dissolve potassium tetrachloroplatinate (K2PtCl4) in PBS to prepare 12.5 mM Pt 2+ Solution.

[0178] (Preparation of Cell Suspension)

[0179] 1.0×10 6 Human breast cancer cells (MDA-MB-231) were suspended in 64 μL of RPMI-1640 medium containing 10% FBS and seeded in the wells of a 24-well culture well plate (CORNING 3470).

[0180] (Preparation and evaluation of three-dimensional tissues)

[0181] <Example 9>

[0182] 224 μL of 0.5 wt % fragmented collagen solution and 12.5 mM Pt were further added to the chamber of the 24-well culture chamber plate seeded with cells. 2+ The solution was suspended in 12 μL and incubated at room temperature for 30 minutes to obtain a cell-containing gel composition. Afterwards, 2 mL of RPMI-1640 culture medium was added to the outside of the chamber, and the culture medium was replaced every other day, and cultured for 4 days to prepare a three-dimensional tissue body. At the time point (the 4th day) of culture for 4 days, a phase contrast microscope (CKX53 manufactured by Olympus) was used to observe the appearance and interior of the three-dimensional tissue body.

[0183] (result)

[0184] Figure 5 (A) is a photograph showing the appearance of a three-dimensional tissue. Figure 5 (B) is a photograph showing the interior of a three-dimensional tissue. Figure 5 (A) and Figure 5 As shown in (B), the three-dimensional tissue obtained in Example 9 has a transparent appearance, although coloring from the culture medium components is visible, so that the internal cells can be observed. 2+ When the solution is mixed and cells are cultured to confirm the cell survival rate, the Pt2+ When the final concentration was 0.05 mM to 0.5 mM, the survival rate was 81% to 87% (no concentration dependence was observed), and no significant difference in cytotoxicity was observed.

[0185] [Test Example 7: Production of gel composition]

[0186] (Preparation of fragmented collagen solution)

[0187] By the same operation as in Test Example 3, a 1 wt % fragmented collagen solution was prepared.

[0188] (Pt 2+ Solution Preparation)

[0189] Potassium tetrachloroplatinate (K2PtCl4) was dissolved in PBS to prepare 25mM, 12.5mM, 2.5mM, 1.25mM, 0.25mM, and 0.125mM Pt 2+ Solution.

[0190] (Au 3+ Solution Preparation)

[0191] Au tetrachlorohydrin (III) acid (HAuCl4) was dissolved in PBS to prepare 25mM, 12.5mM, 2.5mM, 1.25mM, 0.25mM, and 0.125mM Au 3+ Solution.

[0192] (Preparation of gel composition)

[0193] <Example 10>

[0194] 288 μL of 1 wt % fragmented collagen solution and various concentrations of Pt were further added to the chamber of the 24-well culture chamber plate. 2+ Solution or Au 3+ 12 μL of the solution was suspended and incubated at room temperature for 30 minutes to obtain a gel composition. Furthermore, after incubation at 37° C. for 24 hours, the elastic modulus was evaluated. The elastic modulus was measured by the same procedure as in Test Example 1.

[0195] (result)

[0196] Figure 6 Graph showing the elastic modulus of the gel composition prepared from the solution of each metal ion. The horizontal axis represents the final concentration of each metal ion. Figure 6 As shown in Figure 2, as the concentration of metal ions increases, the elastic modulus of the gel increases. 3+ When compared with the solution, Pt 2+Regardless of the metal ion solution used, the elastic modulus of the gel increased in a metal ion concentration-dependent manner until the final concentration reached 0.1 mM, and showed a substantially constant elastic modulus in the concentration range after 0.1 mM.

[0197] [Test Example 8: Production of gel composition]

[0198] (Preparation of fragmented collagen solution)

[0199] A 1 wt % fragmented collagen solution was prepared by the same operation as in Test Example 3. Next, the prepared fragmented collagen solution was diluted with PBS to prepare 0.2 wt % and 0.5 wt % fragmented collagen solutions.

[0200] (Pt 2+ Solution Preparation)

[0201] Potassium tetrachloroplatinate (K2PtCl4) was dissolved in PBS to prepare 12.5mM, 2.5mM, 1.25mM, 0.25mM, and 0.125mM Pt 2+ Solution.

[0202] (Preparation of gel composition)

[0203] <Example 11>

[0204] 288 μL of fragmented collagen solution of various concentrations and Pt of various concentrations were further added to the wells of the 96-well microplate. 2+ 12 μL of the solution was suspended and incubated at room temperature for 30 minutes to obtain a gel composition. After incubation at 37°C for 24 hours, the absorbance at a wavelength of 500 nm was measured and the transmittance was calculated. The elastic modulus was measured in the same manner as in Example 1.

[0205] (result)

[0206] Figure 7 (A) shows the concentrations of fragmented collagen solution and Pt 2+ The graph shows the transmittance of the gel composition prepared from the solution at a wavelength of 500 nm. The horizontal axis represents the metal ion (Pt 2+ ) to a final concentration of Figure 7 As shown in (A), the transmittance of the gel increases with increasing metal ion concentration. In particular, when the final metal ion concentration is 0.05 mM or more, the transmittance is significantly improved compared to when the final metal ion concentration is below 0.05 mM. Figure 7 (B) is a top view of the fragmented collagen solution and Pt 2+ Image of solution-made gel compositions. Figure 7In (B), the value at the center of each hole represents the elastic modulus of the gel composition in the hole. A significant result was observed in which the transmittance increased regardless of the increase in elastic modulus.

[0207] [Test Example 9: Production of gel composition]

[0208] (Preparation of fragmented collagen solution)

[0209] By the same operation as in Test Example 6, a 0.5 wt % fragmented collagen solution was prepared.

[0210] (Pd 2+ Solution Preparation)

[0211] Prepare 12.5 mM Pd by dissolving palladium(II) chloride (PdCl2) in water. 2+ Solution.

[0212] (Cu 2+ Solution Preparation)

[0213] Dissolve copper (II) chloride (CuCl2) in water to prepare 12.5 mM Cu 2+ Solution.

[0214] (Zn 2+ Solution Preparation)

[0215] Dissolve zinc(II) chloride (ZnCl2) in water to prepare 12.5 mM Zn 2+ Solution.

[0216] (Preparation of gel composition)

[0217] <Example 12>

[0218] 480 μL of a 0.5 wt % fragmented collagen solution and 20 μL of each metal ion solution were further added to the glass container for suspension, and incubated at room temperature for 30 minutes to obtain a gel composition. After incubation at 4° C. for 24 hours, the profile was evaluated.

[0219] (result)

[0220] Figure 8 The photographs show the appearance of each composition one day after adding each metal solution. All compositions prepared using any metal ion turned into a transparent gel.

Claims

1. A gel composition comprising: Fragmented extracellular matrix components; and Ions of metal elements, in, The metal element is at least one selected from zinc, palladium, platinum and gold, The fragmented extracellular matrix component comprises fragmented collagen.

2. The gel composition according to claim 1, in, The fragmented extracellular matrix components are cross-linked.

3. The gel composition according to claim 1 or 2, in, The fragmented extracellular matrix component at least comprises an aggregate of extracellular matrix molecules.

4. The gel composition according to claim 1 or 2, in, The fragmented extracellular matrix component is obtained by homogenizing the extracellular matrix component in an aqueous medium.

5. A method for producing a gel composition, comprising the step of bringing a solution containing a fragmented extracellular matrix component into contact with a solution containing ions of a metal element, in, The metal element is at least one selected from zinc, palladium, platinum and gold, and the fragmented extracellular matrix component includes fragmented collagen.

6. The method for producing the gel composition according to claim 5, in, The fragmented extracellular matrix component at least comprises an aggregate of extracellular matrix molecules.

7. The method for producing the gel composition according to claim 5, in, The fragmented extracellular matrix component is obtained by homogenizing the extracellular matrix component in an aqueous medium.

8. A method for producing a three-dimensional tissue, comprising the following steps: A step of obtaining a cell-containing gel composition by contacting fragmented extracellular matrix components, cells, and ions of a metal element in an aqueous medium; and a step of culturing the cell-containing gel composition, in, The metal element is at least one selected from zinc, palladium, platinum and gold, and the fragmented extracellular matrix component includes fragmented collagen.

9. The method for producing a three-dimensional tissue according to claim 8, in, The step of obtaining the cell-containing gel composition includes the step of bringing a solution containing ions of the metal element and a second aqueous medium into contact with a suspension containing the fragmented extracellular matrix component, the cells, and a first aqueous medium.

10. The method for producing a three-dimensional tissue according to claim 8 or 9, in, The culturing step is performed under conditions in which at least a portion of the cells remain alive.

11. The method for producing a three-dimensional tissue according to claim 8 or 9, in, After the step of obtaining the cell-containing gel composition and before the step of culturing, the method further comprises a step of incubating the cell-containing gel composition at 20° C. to 30° C.

12. The method for producing a three-dimensional tissue according to claim 8 or 9, in, The fragmented extracellular matrix component at least comprises an aggregate of extracellular matrix molecules.

13. The method for producing a three-dimensional tissue according to claim 8 or 9, in, The fragmented extracellular matrix component is obtained by homogenizing the extracellular matrix component in an aqueous medium.

14. A three-dimensional tissue containing fragmented extracellular matrix components, cells and ions of metal elements, and being transparent at 37°C. in, The metal element is at least one selected from zinc, palladium, platinum and gold, and the fragmented extracellular matrix component includes fragmented collagen. 15 . The three-dimensional tissue according to claim 14 , which has a total light transmittance of 80% or more at 37° C.

16. The three-dimensional tissue according to claim 14 or 15, in, The fragmented extracellular matrix component at least comprises an aggregate of extracellular matrix molecules.

17. The three-dimensional tissue according to claim 14 or 15, in, The fragmented extracellular matrix component is obtained by homogenizing the extracellular matrix component in an aqueous medium.

Citation Information

Patent Citations

  • Extracellular-matrix-containing composition, temporary scaffold for three-dimensional tissue formation, three-dimensional tissue formation agent, and method for recovering cells from three-dimensional tissue

    WO2019208831A1

  • A pharmaceutical composition used for reducing damage caused by free radicals

    CA2851130A1

  • Extracorporeal blood vessel regenerating model and its application in evaluating the vascularizing function of biomaterial

    CN101045913A

  • Artificial extracellular matrix and preparation method thereof

    CN102188746A

  • Collagen gel containing nanogold, and prepetition method and application thereof

    CN104739657A